Candel Therapeutics Inc (CADL)
Stock-Based Compensation
$2.86M
Quarterly · Period ending: · USD
CADL Stock-Based Compensation
Latest reported$2.86Mperiod ending
Latest reported$2.86Mperiod ending
CADL Quarterly Stock-Based Comp (-$32.00K → $2.86M)
Quarterly stock-based compensation
High-resolution chart · PNG
CADL stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 2,858,000 | |
| 1,452,000 | |
| 1,290,000 | |
| 1,163,000 | |
| 1,050,000 | |
| 314,000 | |
| 1,244,000 | |
| 1,184,000 | |
| 1,841,000 | |
| 1,043,000 | |
| 939,000 | |
| 686,000 | |
| 733,000 | |
| 733,000 | |
| 634,000 | |
| 743,000 | |
| 438,000 | |
| 492,000 | |
| -446,000 | |
| 1,909,000 | |
| 1,069,000 | |
| 431,000 | |
| 1,753,000 | |
| 83,000 | |
| 303,000 | |
| -32,000 |